news
US Food and Drug Administration approves Recarbrio
A three-drug combination injection to treat patients with complicated urinary tract and intra-abdominal infections has been approved by the FDA.
List view / Grid view
Drug Markets
news
Ontario and Quebec against plan to lower Canadian drug prices
The two Canadian provinces have expressed concern over the new draft regulations, claiming that the reforms would delay patient access to medicines.
news
FTC investigates contracts regarding autoimmune disease drug, Remicade
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
news
Indian drug makers looking to expand in Chinese pharma industry
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
news
US sanctions on Iran creating critical drug shortage
The Middle Eastern country has a limited supply of vital medication needed for conditions such as cancer due to US trade blocks.
news
Nubeqa® approved by the US Food and Drug Administration
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.
news
Pharmaceutical robots market to see significant growth
The global pharmaceutical robots market is set to be worth $344.4m at the end of a forecast period, after seeing substantial growth.
news
Brand-brand competition will not reduce prices of drugs in US
A new study undertaken to better understand the economic impact of brand-brand competition finds this does not lower drug prices.
news
Trump drafts plan to import drugs from Canada
In another bid to lower medication prices in the US, Donald Trump has announced a draft plan to import drugs from Canada.
news
AstraZeneca and Novartis set to lose out from US drug prices reforms
A report has suggested that the drug price reforms in the US will affect AstraZeneca and Novartis negatively, but Novo could benefit.
news
Cannabidiol-based treatment receives marketing approval from EMA
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
news
Pharma companies to pay California $70m for drug delays
Teva Pharmaceuticals, Endo Pharmaceuticals and Teikoku will pay almost $70 million to the US state for delaying drugs to keep prices high.
news
EMA recommends Vitrakvi for EU marketing authorisation
The EMA has announced its approval for marketing authorisation in the EU for Vitrakvi (larotrectinib), used to treat solid tumours with a specific gene mutation.
news
Three pharma companies accused of breaking competition law
The CMA alleges that a pharmaceutical company agreed to buy equal quantities of a pill from two drug suppliers, breaking competition law.
news
Pharma processing and packaging equipment market to see growth
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).
